Jefferies Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Jefferies Financial Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.91M	Buy	28,021 +24,929	+806%	+$2.66M	0.02%	489
2025 Q4	$319K	Sell	3,092 -796	-20%	-$77.4K	﹤0.01%	1482
2025 Q3	$351K	Buy	3,888 +626	+19%	+$54.8K	﹤0.01%	1170
2025 Q2	$287K	Buy	+3,262	New	+$283K	﹤0.01%	1044
2024 Q4	–	Sell	-3,340	Closed	-$317K	–	1787
2024 Q3	$317K	Buy	3,340 +388	+13%	+$36.8K	﹤0.01%	1102
2024 Q2	$270K	Buy	+2,952	New	+$264K	﹤0.01%	1140

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Jefferies Financial Group's PPH Position: Q1 2026 in Review

Jefferies Financial Group increased its VanEck Pharmaceutical ETF (PPH) stake by 806% in Q1 2026, buying an estimated $2.66M and bringing the position to 28,021 shares worth $2.91M. The position accounts for 0.02% of the portfolio, ranked #489.

Jefferies Financial Group first reported a position in PPH in Q2 2024 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Jefferies Financial Group held 28,021 shares of VanEck Pharmaceutical ETF worth $2.91M as of Q1 2026.
Jefferies Financial Group bought 24,929 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $2.66M.
VanEck Pharmaceutical ETF made up 0.02% of Jefferies Financial Group's portfolio in Q1 2026, its #489 holding.
Jefferies Financial Group first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 6 quarters since.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.